文献詳細
文献概要
特集 膠原病・自己免疫疾患を「見える化」する 臨床から見える化する 【筋炎】
自己抗体で筋炎を見える化する
著者: 濱口儒人1
所属機関: 1金沢大学医薬保健研究域医学系皮膚分子病態学
ページ範囲:P.2106 - P.2109
文献購入ページに移動Point
◎多発性筋炎/皮膚筋炎では,筋炎特異的自己抗体(MSA)と臨床症状に関連がある.
◎いくつかのMSAはELISA検査試薬が開発されているが,それ以外は同定に免疫沈降法が必要である.
◎MSAを同定するには,蛍光抗体間接法とELISA検査の結果が一致するかを確認する.
◎多発性筋炎/皮膚筋炎では,筋炎特異的自己抗体(MSA)と臨床症状に関連がある.
◎いくつかのMSAはELISA検査試薬が開発されているが,それ以外は同定に免疫沈降法が必要である.
◎MSAを同定するには,蛍光抗体間接法とELISA検査の結果が一致するかを確認する.
参考文献
1)Sato S, et al:Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52:1571-1576, 2005
2)Kaji K, et al:Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis;An association with malignancy. Rheumatology(Oxford)46:25-28, 2007
3)Hamaguchi Y, et al:Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies. Clin Rheumatol, 2020(epub ahead of print)
4)Targoff IN:Autoantibodies in polymyositis. Rheum Dis Clin North Am 18:455-482, 1992
5)Hamaguchi Y, et al:Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies;Heterogeneity within the syndrome. PLoS One 8:e60442, 2013
6)Komura K, et al:Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis. J Dermatol Sci 40:215-217, 2005
7)Tsuji H, et al:Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Arthritis Rheumatol 72:488-498, 2020
8)Matsushita T, et al:Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol 176:395-402, 2017
9)Ichimura Y, et al:Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies;Possible association with malignancy. Ann Rheum Dis 71:710-713, 2012
10)Fujimoto M, et al:Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis;Comparison with a UK Caucasian cohort. Ann Rheum Dis 72:151-153, 2013
11)Suzuki S, et al:Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology(Oxford)47:1539-1542, 2008
掲載誌情報